{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:47Z","timestamp":1791357407310,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sydney Local Heath District"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00213-020-05627-4","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T08:04:43Z","timestamp":1599033883000},"page":"2905-2915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-1946","authenticated-orcid":false,"given":"Omar","family":"Mubaslat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"issue":"3","key":"5627_CR1","first-page":"250","volume":"24","author":"C Antonello","year":"1999","unstructured":"Antonello C, Tessier P (1999) Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect. J Psychiatry Neurosci 24(3):250","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"5627_CR2","first-page":"25","volume":"5","author":"G Bavikatte","year":"2012","unstructured":"Bavikatte G, Sit PL, Hassoon A (2012) Management of drooling of saliva. British Journal of Medical Practitioners 5(1):25","journal-title":"British Journal of Medical Practitioners"},{"issue":"2","key":"5627_CR3","first-page":"576","volume":"260","author":"C Bolden","year":"1992","unstructured":"Bolden C, Cusack B, Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260(2):576\u2013580","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"5627_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40263-019-00612-8","volume":"33","author":"S-Y Chen","year":"2019","unstructured":"Chen S-Y, Ravindran G, Zhang Q, Kisely S, Siskind D (2019 Mar 6) Treatment strategies for clozapine-induced sialorrhea: a systematic review and meta-analysis. CNS drugs 33(3):225\u2013238","journal-title":"CNS drugs"},{"issue":"6","key":"5627_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/000486700285","volume":"34","author":"C Comley","year":"2000","unstructured":"Comley C, Galletly C, Ash D (2000) Use of atropine eye drops for clozapine induced hypersalivation. Aust N Z J Psychiatry 34(6):1033\u20131034","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"5627_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/0269216306071702","volume":"20","author":"GG De Simone","year":"2006","unstructured":"De Simone GG, Eisenchlas JH, Junin M, Pereyra F, Brizuela R (2006) Atropine drops for drooling: a randomized controlled trial. Palliat Med 20(7):665\u2013671","journal-title":"Palliat Med"},{"key":"5627_CR7","doi-asserted-by":"crossref","unstructured":"Ekstr\u00f6m J, Khosravani N, Castagnola M, Messana I. Saliva and the control of its secretion. Dysphagia: Springer; 2011. p. 19\u201347","DOI":"10.1007\/174_2011_481"},{"issue":"3","key":"5627_CR8","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1111\/odi.12139","volume":"20","author":"J Ekstr\u00f6m","year":"2014","unstructured":"Ekstr\u00f6m J, Godoy T, Loy F, Riva A (2014) Parasympathetic vasoactive intestinal peptide (VIP): a likely contributor to clozapine-induced sialorrhoea. Oral Dis 20(3):e90\u2013ee6","journal-title":"Oral Dis"},{"issue":"1","key":"5627_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpainsymman.2012.01.006","volume":"45","author":"M Heisler","year":"2013","unstructured":"Heisler M, Hamilton G, Abbott A, Chengalaram A, Koceja T, Gerkin R (2013) Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle. J Pain Symptom Manag 45(1):14\u201322","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"5627_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/mds.10276","volume":"17","author":"HC Hyson","year":"2002","unstructured":"Hyson HC, Johnson AM, Jog MS (2002) Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 17(6):1318\u20131320","journal-title":"Mov Disord"},{"issue":"2","key":"5627_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1399-6576.1988.tb02691.x","volume":"32","author":"J Kanto","year":"1988","unstructured":"Kanto J, Klotz U (1988) Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate. Acta Anaesthesiol Scand 32(2):69\u201378","journal-title":"Acta Anaesthesiol Scand"},{"key":"5627_CR12","unstructured":"Laurence L. Brunton BAC, Bj\u00f6rn C. Knollmann,. Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 12e ed."},{"issue":"3","key":"5627_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1474-8673.1987.tb00151.x","volume":"7","author":"S Levin","year":"1987","unstructured":"Levin S (1987) Is atropine a pilocarpine antagonist in cases of eliminated parasympathetic innervation of the human parotid salivary gland? J Auton Pharmacol 7(3):215\u2013232","journal-title":"J Auton Pharmacol"},{"issue":"11","key":"5627_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/j.1552-4604.1992.tb03804.x","volume":"32","author":"SL Levin","year":"1992","unstructured":"Levin SL (1992) Salivatory responses to classical and nontraditional parasympatholytic agents in human subjects: critical comments. J Clin Pharmacol 32(11):1013\u20131022","journal-title":"J Clin Pharmacol"},{"issue":"1\u20133","key":"5627_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.schres.2010.02.1060","volume":"119","author":"CS Liang","year":"2010","unstructured":"Liang CS, Ho PS, Shen LJ, Lee WK, Yang FW, Chiang KT (2010) Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. Schizophr Res 119(1\u20133):138\u2013144","journal-title":"Schizophr Res"},{"issue":"9","key":"5627_CR16","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.3390\/toxins7093758","volume":"7","author":"M Mazlan","year":"2015","unstructured":"Mazlan M, Rajasegaran S, Engkasan J, Nawawi O, Goh K-J, Freddy S (2015) A double-blind randomized controlled trial investigating the most efficacious dose of botulinum toxin-a for sialorrhea treatment in Asian adults with neurological diseases. Toxins. 7(9):3758\u20133770","journal-title":"Toxins."},{"key":"5627_CR17","doi-asserted-by":"crossref","unstructured":"McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, et al. (2006) Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","DOI":"10.1176\/ajp.2006.163.4.600"},{"issue":"4","key":"5627_CR18","first-page":"242","volume":"16","author":"FA Mustafa","year":"2013","unstructured":"Mustafa FA, Khan A, Burke J, Cox M, Sherif S (2013) Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea. African Journal of Psychiatry (South Africa) 16(4):242","journal-title":"African Journal of Psychiatry (South Africa)"},{"issue":"2","key":"5627_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00000542-199108000-00008","volume":"75","author":"T Nishikawa","year":"1991","unstructured":"Nishikawa T, Dohi S (1991) Oral clonidine blunts the heart rate response to intravenous atropine in humans. Anesthesiology. 75(2):217\u2013222","journal-title":"Anesthesiology."},{"issue":"3","key":"5627_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00213-005-0248-4","volume":"185","author":"SK Praharaj","year":"2006","unstructured":"Praharaj SK, Arora M, Gandotra S (2006) Clozapine-induced sialorrhea: pathophysiology and management strategies. Psychopharmacology. 185(3):265\u2013273","journal-title":"Psychopharmacology."},{"issue":"4","key":"5627_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/WNF.0b013e3181e204e0","volume":"33","author":"SK Praharaj","year":"2010","unstructured":"Praharaj SK, Jana AK, Goswami K, Das PR, Goyal N, Sinha VK (2010) Salivary flow rate in patients with schizophrenia on clozapine. Clin Neuropharmacol 33(4):176\u2013178","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"5627_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1049909112453641","volume":"30","author":"BM Protus","year":"2013","unstructured":"Protus BM, Grauer PA, Kimbrel JM (2013) Evaluation of atropine 1% ophthalmic solution administered sublingually for the management of terminal respiratory secretions. American Journal of Hospice and Palliative Medicine 30(4):388\u2013392","journal-title":"American Journal of Hospice and Palliative Medicine"},{"issue":"2","key":"5627_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajem.2008.10.025","volume":"28","author":"S Rajpal","year":"2010","unstructured":"Rajpal S, Ali R, Bhatnagar A, Bhandari SK, Mittal G (2010) Clinical and bioavailability studies of sublingually administered atropine sulfate. Am J Emerg Med 28(2):143\u2013150","journal-title":"Am J Emerg Med"},{"issue":"1","key":"5627_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2125.1990.tb03739.x","volume":"30","author":"MU Rashid","year":"1990","unstructured":"Rashid MU, Bateman DN (1990) Effect of intravenous atropine on gastric emptying, paracetamol absorption, salivary flow and heart rate in young and fit elderly volunteers. Br J Clin Pharmacol 30(1):25\u201334","journal-title":"Br J Clin Pharmacol"},{"key":"5627_CR25","first-page":"321","volume-title":"Drooling","author":"C Scully","year":"2009","unstructured":"Scully C, Limeres J, Gleeson M, Tom\u00e1s I, Diz P (2009) Drooling. Blackwell Publishing Ltd, Oxford, pp 321\u2013327"},{"issue":"2","key":"5627_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/YIC.0000000000000251","volume":"34","author":"A Segev","year":"2019","unstructured":"Segev A, Evans A, Hodsoll J, Whiskey E, Sheriff RS, Shergill S, MacCabe JH (2019) Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial. Int Clin Psychopharmacol 34(2):101\u2013107","journal-title":"Int Clin Psychopharmacol"},{"issue":"9","key":"5627_CR27","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1345\/aph.1E077","volume":"38","author":"A Sharma","year":"2004","unstructured":"Sharma A, Ramaswamy S, Dahl E, Dewan V (2004) Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea. Ann Pharmacother 38(9):1538","journal-title":"Ann Pharmacother"},{"issue":"8","key":"5627_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.4088\/JCP.08m04495","volume":"70","author":"S Sockalingam","year":"2009","unstructured":"Sockalingam S, Shammi C, Remington G (2009) Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study. The Journal of clinical psychiatry 70(8):1114\u20131119","journal-title":"The Journal of clinical psychiatry"},{"key":"5627_CR29","first-page":"CD005579","volume":"3","author":"R Syed","year":"2008","unstructured":"Syed R, Au K, Cahill C, Duggan L, He Y, Udu V et al (2008) Pharmacological interventions for clozapine-induced hypersalivation. Cochrane Database Syst Rev 3:CD005579","journal-title":"Cochrane Database Syst Rev"},{"key":"5627_CR30","unstructured":"Therapeutic Goods Administration (2018) Off-label use of atropine. Medicines Safety Update [Internet]. 9(3). Available from: https:\/\/www.tga.gov.au\/publication-issue\/medicines-safety-update-volume-9-number-3-august-september-2018"},{"issue":"1","key":"5627_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF00168807","volume":"338","author":"A Wellstein","year":"1988","unstructured":"Wellstein A, Pitschner H (1988) Complex dose-response curves of atropine in man explained by different functions of M1-and M2-cholinoceptors. Naunyn Schmiedeberg\u2019s Arch Pharmacol 338(1):19\u201327","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"4","key":"5627_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1748-1716.1990.tb08870.x","volume":"138","author":"A Westlind-Danielsson","year":"1990","unstructured":"Westlind-Danielsson A, M\u00fcller RM, Bartfai T (1990) Atropine treatment induced cholinergic supersensitivity at receptor and second messenger levels in the rat salivary gland. Acta Physiol Scand 138(4):431\u2013441","journal-title":"Acta Physiol Scand"},{"issue":"4","key":"5627_CR33","first-page":"275","volume":"23","author":"S Yesilyurt","year":"2010","unstructured":"Yesilyurt S, Aras I, Altinbas K, Atag\u00fcn MI, Kurt E (2010) Pathophysiology of clozapine induced sialorrhea and current treatment choices. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 23(4):275","journal-title":"Dusunen Adam The Journal of Psychiatry and Neurological Sciences"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05627-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:33:33Z","timestamp":1630539213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05627-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5627"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05627-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures were approved by Sydney Local Health District Human Research Ethics Committee (approval number HREC\/16\/CRGH\/265), Concord Repatriation General Hospital, Australia. Written informed consent was obtained from all participants after discussing the study purpose and procedure with the researchers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}